Business Combination - Additional Information (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Feb. 12, 2026 |
Feb. 12, 2026 |
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Business Combination [Line Items] | |||||||||||
| Ordinary shares, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||
| Recognized share-based compensation expense | $ 18,400,000 | $ 100,000 | $ 400,000 | ||||||||
| Total revenues | 480,132,000 | $ 394,185,000 | 1,369,052,000 | $ 1,091,352,000 | |||||||
| Net Income (Loss) | 16,287,000 | $ 501,000 | $ (66,480,000) | $ 82,761,000 | $ 87,098,000 | $ 22,464,000 | (49,692,000) | $ 192,323,000 | |||
| Avadel Pharmaceuticals Plc | |||||||||||
| Business Combination [Line Items] | |||||||||||
| Issued ordinary share | $ 21 | $ 21 | |||||||||
| Ordinary shares, par value (in dollars per share) | 0.01 | 0.01 | |||||||||
| Potential additional cash payment per share upon achievement of certain specific milestone | $ 1.5 | $ 1.5 | |||||||||
| Contingent payments | $ 165,700,000 | $ 165,700,000 | 165,700,000 | 165,700,000 | |||||||
| Contingent consideration liability | 107,700,000 | 107,700,000 | |||||||||
| Purchase price | 134,900,000 | ||||||||||
| Recognized share-based compensation expense | 1,800,000 | ||||||||||
| Total revenues | 89,900,000 | 226,000,000 | |||||||||
| Deferred tax liability | 183,129,000 | 183,129,000 | 183,100,000 | 183,100,000 | |||||||
| Deferred tax assets | 849,000 | 849,000 | 800,000 | 800,000 | |||||||
| Uncertain tax position in connection with U.S. state tax position | 2,200,000 | 2,200,000 | |||||||||
| Adjustments to reduce deferred tax asset | 400,000 | 400,000 | |||||||||
| Adjustments in reduction of estimated value of goodwill | 1,800 | 1,800 | |||||||||
| Transaction costs | 1,500,000 | 1,500,000 | |||||||||
| Acquisition related costs | 37,400,000 | 37,400,000 | |||||||||
| Direct one-time transaction costs | $ 64,600,000 | $ 77,700,000 | $ 77,700,000 | ||||||||
| Direct one-time acquisition transaction costs | 45,600,000 | $ 9,700,000 | |||||||||
| Acceleration of unvested share-based compensation awards | $ 20,200,000 | ||||||||||
| X | ||||||||||
- Definition Business acquisition potential additional cash payment per share upon achievement of specific milestone. No definition available.
|
| X | ||||||||||
- Definition Business combination adjustments in reduction of estimated value of goodwill. No definition available.
|
| X | ||||||||||
- Definition Business combination adjustments to reduce deferred tax asset. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, acceleration of unvested share-based compensation awards. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, direct one-time transaction costs. No definition available.
|
| X | ||||||||||
- Definition Business combination, pro forma information, direct one time acquisition transaction costs. No definition available.
|
| X | ||||||||||
- Definition Business combination, recognized share-based compensation expense. No definition available.
|
| X | ||||||||||
- Definition Business combination uncertain tax position in connection with U S state tax position. No definition available.
|
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Purchase price of expected business acquisition prior to consideration being transferred. Excludes asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
| X | ||||||||||
- Details
|